Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study

BACKGROUND Clinicoepidemiological findings indicate that symptomatic heart involvement in patients with systemic sclerosis (SSc) predicts a very poor prognosis. At necropsy studies, SSc heart involvement without significant coronary lesions is characterised by patchy myocyte necrosis and contraction band necrosis with collagen replacement leading to myocardial fibrosis. There is a discrepancy between the frequency of clinically evident myocardial disease (25%) and autoptical myocardial fibrosis (81%). OBJECTIVE The aim of this study was to detect preclinical myocardial alterations in SSc patients by ultrasonic videodensitometric analysis. METHODS Thirty five SSc patients (three male, aged 48.6 (11) SD years, range 22–65) with normal ventricular function and 25 age and sex matched healthy controls were studied. All patients had a negative maximal exercise stress; in all cases arterial hypertension, renal involvement, and diabetes were excluded. Echocardiographic images were digitised by a real time videodigitiser (Tomtec Imaging Systems). Quantitative texture analysis was performed on data from the septum and the posterior wall, obtaining mean gray level histogram (MGL) at both end-diastole (d) and end-systole (s). The cyclic variation index (CVI), was calculated according to the formula ((MGLd−MGLs)/MGLd) × 100. Left ventricular mass (LVM), body surface corrected, was calculated according to Penn convention. RESULTS Comparable systolic and diastolic blood pressure, LVM, diastolic and systolic function were recorded in both SSc patients and controls. In contrast, in SSc patients the CVI, which is the expression of the intrinsic myocardial structural function, was significantly lower than in controls (septum: −18 (28)%v 35 (10)%, p<0.0001; and posterior wall: −13 (32)%v 50 (20)%, p<0.0001). Changes in cyclic echo amplitude, probably related to myocardial fibrosis, were detected in the large majority of SSc patients (88%). CONCLUSIONS Ultrasonic videodensitometric analysis represents a non-invasive, feasible method that can detect early myocardial changes in SSc patients, which could be related to both fibrosis and microcirculatory abnormalities. Their potential evolution towards ventricular dysfunction and their link with cardiac sudden death, because of severe conduction system or rhythm disturbancies, should be further investigated.

[1]  D. Furst,et al.  The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. , 1981, Annals of internal medicine.

[2]  P. Venables,et al.  Purification and characterization of the Sjögren's syndrome A and B antigens. , 1983, Clinical and experimental immunology.

[3]  Miller Tr,et al.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). , 1990, The Journal of rheumatology.

[4]  Leroy Ec,et al.  A modified scleroderma skin scoring method. , 1986 .

[5]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[6]  J. Fries,et al.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. , 1969, The American journal of medicine.

[7]  C Giusti,et al.  Ultrasonic videodensitometric analysis of two different models of left ventricular hypertrophy. Athlete's heart and hypertension. , 1997, Hypertension.

[8]  G. Pasero,et al.  Cutaneous and serologic subsets of systemic sclerosis. , 1991, The Journal of rheumatology.

[9]  T. Medsger,et al.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. , 1988, Arthritis and rheumatism.

[10]  H. Paulus,et al.  The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). , 1981, The American journal of medicine.

[11]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[12]  A J Tajik,et al.  Feasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic data. , 1989, Journal of the American College of Cardiology.

[13]  E. Topol,et al.  Pulsed Doppler assessment of left ventricular diastolic filling in coronary artery disease before and immediately after coronary angioplasty. , 1987, The American journal of cardiology.

[14]  R Hetzer,et al.  Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. , 1996, European heart journal.

[15]  J. G. Miller,et al.  Ultrasonic characterization of myocardium. , 1985, Progress in cardiovascular diseases.

[16]  S. M. Collins,et al.  Detection of Acute Myocardial Infarction in Closed‐ Chest Dogs by Analysis of Regional Two‐Dimensional Echocardiographic Gray‐Level Distributions , 1983, Circulation research.

[17]  G. Hutchins,et al.  Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. , 1978, American heart journal.

[18]  E. Tan,et al.  Autoantibody to centromere (kinetochore) in scleroderma sera. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Pasero,et al.  Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. , 1997, British journal of rheumatology.

[20]  B. Amor,et al.  Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. , 1986, The New England journal of medicine.

[21]  T. N. James,et al.  De Subitaneis Mortibus: VIII. Coronary Arteries and Conduction System in Scleroderma Heart Disease , 1974, Circulation.

[22]  E. Leroy,et al.  Pericardial disease in scleroderma (systemic sclerosis). , 1974, The American journal of medicine.

[23]  E Picano,et al.  Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of myocardial amyloidosis. , 1989, Journal of the American College of Cardiology.

[24]  S. M. Collins,et al.  Quantitative texture analysis in two-dimensional echocardiography: application to the diagnosis of experimental myocardial contusion. , 1983, Circulation.

[25]  T. Medsger,et al.  Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. , 1984, The New England journal of medicine.

[26]  D. Gibson,et al.  Changes in myocardial echo amplitude during reversible ischaemia in humans. , 1992, British heart journal.

[27]  G. Hutchins,et al.  Myocardial Lesions of Progressive Systemic Sclerosis: A Cause of Cardiac Dysfunction , 1976, Circulation.

[28]  G. Hughes,et al.  Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. , 1982, Journal of clinical & laboratory immunology.

[29]  J. Weiss,et al.  Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. , 1986, Annals of internal medicine.

[30]  D. Gibson,et al.  Clinical application of amplitude processing of echocardiographic images. , 1981, British heart journal.

[31]  George A. Williams,et al.  Effect of aging on left ventricular diastolic filling in normal subjects. , 1987, The American journal of cardiology.

[32]  L. Landini,et al.  Increased echodensity of transiently asynergic myocardium in humans: a novel echocardiographic sign of myocardial ischemia. , 1993, Journal of the American College of Cardiology.

[33]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[34]  Elena Matteucci,et al.  Ultrasonic videodensitometric analysis in type 1 diabetic myocardium , 1996, Coronary artery disease.

[35]  C. Loadholt,et al.  A modified scleroderma skin scoring method. , 1986, Clinical and experimental rheumatology.

[36]  H. Maricq,et al.  Widefield capillary microscopy. technique and rating scale for abnormalities seen in scleroderma and related disorders , 1981 .

[37]  A. Romorini,et al.  [Cardiac involvement in scleroderma]. , 1988, Medicina cutanea ibero-latino-americana.

[38]  J. G. Miller,et al.  Quantitative characterization of myocardium with ultrasonic imaging. , 1988, The Journal of nuclear medicine and allied sciences.

[39]  J. G. Miller,et al.  A relationship between ultrasonic integrated backscatter and myocardial contractile function. , 1985, The Journal of clinical investigation.

[40]  B. Amor,et al.  Decreased coronary reserve in primary scleroderma myocardial disease. , 1985, Arthritis and rheumatism.

[41]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[42]  G. Pasero,et al.  Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. , 1985, Arthritis and rheumatism.